Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities.
Olympus Corp. shares tumbled the most since April 2025 after the US Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections the agency previously conducted at six facilities.
<iframe src="https://statesidedaily.com/embed/cluster/6f9a92e057d8f3e4374045b18ed37997dec8b6f9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Olympus Shares Slump on FDA Warning Letter on Six Facilities"></iframe>